Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Net Equity Issued and Repurchased (2022 - 2025)

Canton Strategic Holdings' (CNTN) quarterly Net Equity Issued and Repurchased came in at $99.1 million in Q4 2025, up 893.89% on a QoQ basis from $10.0 million in Q4 2023.

Analysis

Canton Strategic Holdings (CNTN) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

Canton Strategic Holdings (CNTN) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $99.1 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $99.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $108.7 million (changed N/A YoY) and the FY2025 annual result came in at $99.4 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased climbed to $99.1 million in Q4 2025, from $10.0 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $99.1 million in Q4 2025 to a low of -$386174.0 in Q3 2023.
  • A 3-year average of $30.6 million and a median of $11.8 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 99.10 Mn
Dec 31, 2023 9.97 Mn
Sep 30, 2023 -386,174.00
Mar 31, 2022 13.65 Mn